Sentinel COVID-19 Evidence Accelerator Series

The Sentinel Initiative participates in the COVID-19 Evidence Accelerator led by the Reagan-Udall Foundation and Friends of Cancer Research. This public-private partnership combines the efforts of academic, government, and private-sector organizations that apply data analytics to accelerate the understanding of COVID-19.

This collaborative effort has mobilized major data organizations, government and academic researchers, and health systems to maximize the use of real-world data. As the lead research team in one of the Evidence Accelerator Parallel Analyses workstreams, the Sentinel Natural History of Coagulopathy in COVID-19 workgroup has presented projects and led critical discussions on conducting observational analyses in COVID-19 across organizations. Key presentations to the Evidence Accelerator forum on the Natural History of Coagulopathy in COVID-19 and other Sentinel COVID-19 activities are linked below.